Showing 48,241 - 48,260 results of 52,669 for search 'CJ7~', query time: 1.31s Refine Results
  1. 48241
  2. 48242

    Differential Role of NKG2A/HLA-E Interaction in the Outcomes of Bladder Cancer Patients Treated with <i>M. bovis</i> BCG or Other Therapies by Inmaculada Ruiz-Lorente, Lourdes Gimeno, Alicia López-Abad, Pedro López Cubillana, Tomás Fernández Aparicio, Lucas Jesús Asensio Egea, Juan Moreno Avilés, Gloria Doñate Iñiguez, Pablo Luis Guzmán Martínez-Valls, Gerardo Server, Belén Ferri, José Antonio Campillo, María Victoria Martínez-Sánchez, Alfredo Minguela

    Published 2025-01-01
    “…The MM genotype, compared to MT and TT, was associated with a longer 75th-percentile overall survival (not reached vs. 68.0 ± 13.7 and 52.0 ± 8.3 months, <i>p</i> = 0.034) in BCG, but a shorter (8.0 ± 2.4 vs. 21.0 ± 3.4 and 19.0 ± 4.9 months, <i>p</i> = 0.131) survival in other treatments. …”
    Get full text
    Article
  3. 48243

    Dose effects of iron on growth, antioxidant potential, intestinal morphology, and intestinal barrier in yellow-feathered broilers by J. Chen, K.W. Lei, S.Y. Li, D.P. Li, Y.L. Wang, X. Wang, X. Bai, Y.L. Huang

    Published 2025-03-01
    “…Chronic iron exposure (≥ 160 mg/kg) can damage the intestinal barrier function, and further increase of Fe supplementation can lead to oxidative stress and even cause growth inhibition for yellow-feathered broilers.…”
    Get full text
    Article
  4. 48244

    The Role of Open and Distance Learning (ODL) in Promoting Access to Women's Education in Northwestern Nigeria: A Case Study of the National Open University of Nigeria (NOUN) by Shehu Usman Adamu, Bala Kwata Waziri, Adewale Adesina, Babangida Iro

    Published 2024-12-01
    “…L’étude a également examiné les facultés où ces femmes se sont inscrites au cours des 4 dernières années afin de déterminer le rôle de l’enseignement ouvert et à distance dans l’accès des femmes à l’enseignement supérieur. …”
    Get full text
    Article
  5. 48245

    Effect of Transcranial Direct Current Stimulation in the Treatment of Aphasia after Stroke:A Meta-Analysis by CUI Ying, LI Bo, TIAN Guang

    Published 2022-12-01
    “…The results of meta-analysis showed that, (1) Clinical efficacy: compared with the control group, the clinical effect of the experimental group was higher [<italic>OR</italic>=3.46, 95% <italic>CI</italic> (2.30, 5.21), <italic>P</italic>&lt;0.001]. (2) WAB score: compared with the control group, the WAB- aphasia quotient (WAB-AQ) score of the experimental group was significantly higher [<italic>MD</italic>=14.06, 95% <italic>CI</italic> (11.82, 16.29), <italic>Z</italic>=12.32, <italic>P</italic>&lt;0.000 01],WAB-spontaneous language score was significantly higher [<italic>MD</italic>=2.13, 95% <italic>CI</italic> (1.32, 2.94), <italic>Z</italic>=5.17, <italic>P</italic>&lt;0.000 01], WAB-listening comprehension score was significantly higher [<italic>MD</italic>=0.50, 95% <italic>CI</italic> (0.05,0.95)], <italic>Z</italic>=2.20, <italic>P</italic>=0.03], WAB-retelling score was significantly higher [<italic>MD</italic>=2.58,95% <italic>CI</italic> (2.18,2.98), <italic>Z</italic>=12.54, <italic>P</italic>&lt;0.000 01] and WAB-naming score was significantly higher [<italic>MD</italic>=2.07, 95% <italic>CI</italic> (1.63, 2.50), <italic>Z</italic>=9.28, <italic>P</italic>&lt;0.000 01]. (3) Picture naming test: compared with the control group, the score of picture naming test in the experimental group was higher [<italic>MD</italic>=23.17, 95% <italic>CI</italic> (10.11, 36.23), <italic>Z</italic>=3.48, <italic>P</italic>=0.000 5]. (4) CADL score: compared with the control group, the CADL score of the experimental group was higher [<italic>MD</italic>=15.08, 95% <italic>CI</italic> (10.88, 19.27), <italic>Z</italic>=7.05, <italic>P</italic>&lt;0.000 01].ConclusiontDCS can effectively improve the communication ability of daily life, picture naming ability and language abilities of spontaneous language, listening comprehension, retelling and naming in patients with aphasia after stroke, with clinical efficacy and good safety. …”
    Get full text
    Article
  6. 48246

    Assessing Facial Thermal Nociceptive Response in Female Dogs After Elective Ovariohysterectomy Anesthetized with Isoflurane and Treated with Cannabidiol and Meloxicam Analgesia by Alejandro Casas-Alvarado, Patricia Mora-Medina, Ismael Hernández-Avalos, Julio Martínez-Burnes, Agatha Miranda-Cortes, Adriana Domínguez-Oliva, Daniel Mota-Rojas

    Published 2025-01-01
    “…The objective of this study was to assess the facial thermal nociceptive response produced by the use of cannabidiol (CBD) alone and in combination with meloxicam in female dogs undergoing elective ovariohysterectomy anesthetized with isoflurane. …”
    Get full text
    Article
  7. 48247

    The IL-1B Gene Polymorphisms rs16944 and rs1143627 Contribute to an Increased Risk of Coronary Artery Lesions in Southern Chinese Children with Kawasaki Disease by Lan Yan Fu, Xiantao Qiu, Qiu Lian Deng, Ping Huang, Lei Pi, Yufen Xu, Di Che, Huazhong Zhou, Zhaoliang Lu, Yaqian Tan, Zhiyong Jiang, Li Zhang, Techang Liu, Xiaoqiong Gu

    Published 2019-01-01
    “…However, in further stratified analysis, we found that children younger than 12 months with the rs16944 GG and rs1143627 AA genotypes of IL-1B had a higher risk of CALs than those with the AA/AG genotypes of rs16944 and GG/AG genotypes of rs1143627 (OR=2.28, 95% CI=1.32-3.95, P=0.0032, adjusted OR=2.33, 95% CI=1.34-4.04, P=0.0027). …”
    Get full text
    Article
  8. 48248

    改良简化的Ferriman-Gallwey 评分系统在中国女性多毛评价中的应用分析 by 赵晓苗, 杨亚波, 陈晓莉, 杨冬梓

    Published 2017-01-01
    “…9 个部位的多毛评分中,mFG 总分在各组中分别为:1.65 ± 0.60、2.30 ± 0.45、3.60 ± 0.68、4.20 ± 0.41 和 4.40 ± 0.77。身体不同部位新生终毛出现的先后顺序依次为:上腹部、下腹部、下背部、上唇、大腿、上背、胸部、上臂和下颌。…”
    Get full text
    Article
  9. 48249
  10. 48250

    FTO rs17817449 Variant Increases the Risk of Severe Obesity in a Brazilian Cohort: A Case-Control Study by Salum KCR, Assis ISS, Kopke ÚA, Palhinha L, Abreu GM, Gouvêa LW, Teixeira MR, Mattos FCC, Nogueira Neto JF, Felício RFM, Rosado EL, Zembrzuski VM, Campos Junior M, Maya-Monteiro CM, Cabello PH, Carneiro JRI, Bozza PT, Kohlrausch FB, da Fonseca ACP

    Published 2025-01-01
    “…Kaio Cezar Rodrigues Salum,1,2 Izadora Sthephanie da Silva Assis,1,2 Úrsula de Almeida Kopke,3 Lohanna Palhinha,4 Gabriella de Medeiros Abreu,2,5 Laura Wendling Gouvêa,1,2 Myrela Ribeiro Teixeira,2,6,7 Fernanda Cristina C Mattos,5 José Firmino Nogueira Neto,8 Rafaela de Freitas Martins Felício,9,10 Eliane Lopes Rosado,5 Verônica Marques Zembrzuski,2 Mario Campos Junior,2 Clarissa Menezes Maya-Monteiro,4 Pedro Hernán Cabello,2 João Regis Ivar Carneiro,1 Patrícia Torres Bozza,4 Fabiana Barzotto Kohlrausch,6 Ana Carolina Proença da Fonseca2,4,11 1Medical Clinic Department, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; 2Human Genetics Laboratory, Oswaldo Cruz Institute, Rio de Janeiro, Brazil; 3Chester Medical School, University of Chester, Chester, UK; 4Laboratory of Immunopharmacology, Oswaldo Cruz Institute, Rio de Janeiro, Brazil; 5Institute of Nutrition Josué de Castro, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil; 6Human Genetics Laboratory, Institute of Biology, Federal Fluminense University Niterói, Rio de Janeiro, Brazil; 7Postgraduate in Sciences and Biotechnology, Fluminense Federal University Niterói, Rio de Janeiro, Brazil; 8Department of Pathology and Laboratory, Rio de Janeiro State University, Rio de Janeiro, Brazil; 9Birth Defect Epidemiology laboratory, Oswaldo Cruz Institute, Rio de Janeiro, Brazil; 10Health Care Network for Congenital Anomalies of the Central Nervous System, Instituto Oswaldo Cruz, Rio de Janeiro, Brazil; 11Genetics Laboratory, Grande Rio University, Rio de Janeiro, BrazilCorrespondence: Ana Carolina Proença da Fonseca, Laboratory of Immunopharmacology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation (Fiocruz), 4365 Brasil Avenue, 108 Building – Office 44, Rio de Janeiro, 21040-360, Brazil, Tel +55(21)38658192, Email ana.proenca@ioc.fiocruz.br Kaio Cezar Rodrigues Salum, Human Genetics Laboratory, Oswaldo Cruz Institute, Oswaldo Cruz Foundation (Fiocruz), 4365 Brasil Avenue, Leônidas Deane Building – Office 611/615, Rio de Janeiro, 21040-360, Brazil, Tel +55 21 38658213, Fax +55 21 38658239, Email kaio.salum@hotmail.comPurpose: Obesity is a complex disease caused by a combination of genetic, environmental, and epigenetic factors, and is associated with an increased risk of chronic diseases. …”
    Get full text
    Article
  11. 48251

    Associations of arthritis with functional disability and depressive symptoms in general US adults: NHANES 1988–1994 and 1999–2018 by Xiaoting Liu, Yunzhen Huang, Jinjing Fu, Mayila Mohedaner, Danzengzhuoga, Gan Yang, Zhenqing Yang, Xueqin Li, Xinye Ma, Qiqi Zhang, Zuyun Liu, Xifeng Wu, Zhimin Ying

    Published 2024-12-01
    “…After controlling for all covariates, self‐reported arthritis was associated with ADL disability (odds ratios [OR]: 2.677; 95% confidence interval [CI]: 2.499–2.868), IADL disability (OR: 2.064; 95% CI: 1.940–2.196), and mobility disability (OR: 2.954; 95% CI: 2.778–3.142), and depressive symptom (OR: 2.177; 95% CI: 1.979–2.395). …”
    Get full text
    Article
  12. 48252
  13. 48253

    Weight-based enoxaparin thromboprophylaxis in young trauma patients: analysis of the CLOTT-1 registry by Sarah Lombardo, Ram Nirula, Elliott R Haut, Scott Brakenridge, Brandon Bruns, Charles E Wade, M Margaret Knudson, Thomas Scalea, Todd W Costantini, Lisa Marie Knowlton, David Spain, Ernest E Moore, Michelle K McNutt, Matthew J Martin, Andrew J Kerwin, George C Velmahos, Bruce Crookes, Marta McCrum, Lucy Kornblith, Mark D Cipolle, Laszlo N Kiraly, David J Milia, Alicia Mohr, Frederick Rogers, Sherry Sixta, Jade Nunez

    Published 2024-07-01
    “…Early prophylaxis was associated with lower VTE rate (1.4% vs. 5.0%; p=0.001) and deep vein thrombosis (0.9% vs. 4.4%; p&lt;0.001), but not pulmonary embolism (0.7% vs. 1.4%; p=0.259). After adjustment, VTE incidence did not differ by dosing strategy (adjusted OR (aOR) 0.75, 95% CI 0.38 to 1.48); however, early administration was associated with a significant reduction in VTE (aOR 0.47, 95% CI 0.30 to 0.74).Conclusion In young trauma patients, WB prophylaxis is not associated with reduced VTE rate when compared with SFD. …”
    Get full text
    Article
  14. 48254

    Функція зовнішнього дихання та дифузійна здатність легень у пацієнтів із різними формами легеневої гіпертензії... by S. O. Progonov, O. O. Torbas, S. M. Kushnir, Yu. M. Sirenko, G. D. Radchenko

    Published 2024-11-01
    “…Наявність ДЗЛМВ < 64 % корелювала з рівнем гемоглобіну (r = –0,31; p = 0,022), дистанцією 6-ХТ (r = –0,35; p = 0,012), SaО2 (r = –0,29; p = 0,036) та TAPSE (r = –0,34, p = 0,012) та рівнем N-КМНУП (r = 0,27; p = 0,048). Незалежними предикторами зниженої ДЗЛМВ були рівень гемоглобіну (β = 0,95; довірчий інтервал (ДІ) 0,90–0,99), SaО2 (β = 0,75; ДІ 0,58–0,95) та TAPSE (β = 0,75; ДІ 0,63–0,91). …”
    Get full text
    Article
  15. 48255

    Abnormal preoperative haematological parameters in Endometrial cancer; reflecting tumour aggressiveness or reduced response to radiotherapy? by Stephanie W. Vrede, Hannah Donkers, Casper Reijnen, Anke Smits, Nicole C.M. Visser, Peggy M. Geomini, Huy Ngo, Dennis van Hamont, Brenda M. Pijlman, Maria Caroline Vos, Marc P.L.M. Snijders, Roy Kruitwagen, Ruud L.M. Bekkers, Khadra Galaal, Johanna M.A. Pijnenborg

    Published 2024-12-01
    “…Anaemia was present in 103 (11.5%), thrombocytosis in 79 (8.8%) and leucocytosis in 114 (12.7%) patients. The presence of anaemia or thrombocytosis was significantly associated with ESGO/ESTRO/ESP high-risk (respectively, P = 0.002 and P = 0.041). …”
    Get full text
    Article
  16. 48256

    شناسایی و بررسی سیلیمارین قارچ اﻧﺪوﻓﻳﺖ ﺟﺪاﺳﺎزی شده از بذر گیاه خارمریم (Silybum marianum (L) Gaert.) by هدی السادات عقیلی, حسین مرادی, محمد علی تاجیک قنبری, ولی الله قاسمی

    Published 2020-11-01
    “…مقدار سیلیمارین برای نمونه برگ تهیه شده از گیاه خودرو در محوطه دانشگاه، ppm 079/33 و برای گیاه استریل درون شیشه ppm 183/17 و برای قارچ اندوفیت ppm 29/7 اندازه‌گیری شد. …”
    Get full text
    Article
  17. 48257
  18. 48258

    Intimate partner violence among women of reproductive age during the COVID-19 pandemic in Ethiopia: a systematic review and meta-analysis by Gizachew Yilak, Alemayehu Sayih Belay, Aychew Kassie, Befkad Derese Tilahun, Ambaw Abebaw Emrie, Mulat Ayele, Eyob Shitie Lake, Legese Fekede Abza

    Published 2025-02-01
    “…Different factors such as: age of the young women (adjusted odds ratio (AOR)=3.24; 95% CI 0.6, 5.8, p=0.015), lack of formal education (AOR=2.63; 95% CI 1.7, 3.6, p=0.000), partner’s substance use (AOR=2.07; 95% CI 1.5, 2.7, p=0.000), partner not attending formal education (AOR=3.38; 95% CI 2.2, 4.6, p=0.000) and partner’s alcohol use (AOR=2.82; 95% CI 1.1, 4.6, p=0.000) were found to be significantly associated with IPV among women during the COVID-19 pandemic.Conclusions In this study, a third of women of reproductive age experienced IPV during the COVID-19 pandemic. …”
    Get full text
    Article
  19. 48259

    Surface Planarization‐Epitaxial Growth Enables Uniform 2D/3D Heterojunctions for Efficient and Stable Perovskite Solar Modules by Dongxu Lin, Jun Fang, Sibo Li, Zhenye Zhan, Huan Li, Xin Wang, Guanshui Xie, Daozeng Wang, Nuanshan Huang, Haichen Peng, Weiguang Xie, Luis K. Ono, Yabing Qi, Longbin Qiu

    Published 2025-01-01
    “…To demonstrate the universality of the strategy applied for different perovskites, the champion device based on a 1.57 eV bandgap 3D perovskite results in an efficiency of 25.31% with a record fill factor of 87.6%. …”
    Get full text
    Article
  20. 48260

    Risk of hepatocellular carcinoma in Asian patients with primary biliary cholangitis: A nationwide and hospital cohort study by Jihye Lim, Ye-Jee Kim, Sehee Kim, Jonggi Choi

    Published 2025-02-01
    “…Twenty-three of the 862 patients with PBC developed HCC in the multicenter hospital cohort, yielding an incidence of 4.0/1,000 PYs (95% CI: 2.4–5.7). Older age (subdistribution hazard ratio [SHR]: 1.05, 95% CI: 1.00–1.10), male sex (SHR: 3.00, 95% CI: 1.11–8.13), current alcohol consumption (SHR: 3.70, 95% CI: 1.08–12.59), and cirrhosis (SHR: 5.17, 95% CI: 2.07–12.93) were identified as risk factors in the hospital cohort. …”
    Get full text
    Article